CN Patent
CN110664756B — 一种小儿外伤喷雾剂及其制备方法
Assigned to First Hospital Jinlin University · Expires 2020-11-17 · 5y expired
What this patent protects
本发明公开了一种小儿外伤喷雾剂及其制备方法。所述小儿外伤喷雾剂由5‑氯‑7‑(3‑羟基‑丙氧基)‑3‑硝基甲基‑3H‑苯并[c][1,2]氧杂硼杂环戊二烯‑1‑醇、冰片、对‑甲氧基肉桂酸辛酯、异丙醇、甲基乙基酮、吐温80、依地酸二钠和纯化水制成,呈溶液形式,具有优异的促进小儿外伤伤口,特别是出血性外伤伤口愈合的功能。
USPTO Abstract
本发明公开了一种小儿外伤喷雾剂及其制备方法。所述小儿外伤喷雾剂由5‑氯‑7‑(3‑羟基‑丙氧基)‑3‑硝基甲基‑3H‑苯并[c][1,2]氧杂硼杂环戊二烯‑1‑醇、冰片、对‑甲氧基肉桂酸辛酯、异丙醇、甲基乙基酮、吐温80、依地酸二钠和纯化水制成,呈溶液形式,具有优异的促进小儿外伤伤口,特别是出血性外伤伤口愈合的功能。
Drugs covered by this patent
- Eucrisa (Crisaborole) · Anacor Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.